^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
AmoyDx® MSI detection kit

Type:
Other Approval
Related tests:
Evidence

News

1year
AmoyDx® Microsatellite Instability (MSI) Detection kit received NMPA approval for pan-tumor immunotherapy companion diagnostics (AmoyDx Press Release)
"National Medical Products Administration (NMPA) granted approval to AmoyDx® Microsatellite Instability (MSI) Detection Kit, making it the first-of-its-kind pan-cancer immunotherapy companion diagnostic kit for market in China."
Non-US regulatory
|
AmoyDx® MSI detection kit